Martin Angel, Federico Losco, Gonzalo Enrique Taetti, Victor Chernobilsky, Federico Cayol, Matias Gonzalez, Hernan Cutuli, Gabriela Gatica, Gonzalo Vitagliano, Tomas Soule, Juan Camean, Juan Pablo Sade, Gustavo Villoldo. "A phase II trial of intravesical gemcitabine/docetaxel plus systemic pembrolizumab in high-risk non–muscle invasive bladder cancer unresponsive to BCG.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.7_suppl.tps888